世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
トピックス別レポート一覧 医療ITの市場調査レポート
- 医療
-
- 医療IT
- このリストはクラウドコンピューティングやスマートデバイスというIT技術を用いた医療関係のレポートを新着順に紹介しています。
- Glucagon Like Peptide 2 Receptor (GLP2R) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 3,500 ｜ Global Markets Direct ｜ 2022年9月 ｜ 英文レポート
- Glucagon Like Peptide 2 Receptor (GLP2R) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report 'Glucagon Like Peptide 2 Receptor - Drugs In Development, 2022'; Glu…
- このレポートの詳細ページはこちら
- Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 3,500 ｜ Global Markets Direct ｜ 2022年9月 ｜ 英文レポート
- Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pr…
- このレポートの詳細ページはこちら
- C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 3,500 ｜ Global Markets Direct ｜ 2022年9月 ｜ 英文レポート
- C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) pipeline Target constitutes close to 1…
- このレポートの詳細ページはこちら
- C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 3,500 ｜ Global Markets Direct ｜ 2022年9月 ｜ 英文レポート
- C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report 'C-C Chemokine Receptor T…
- このレポートの詳細ページはこちら
- Catenin Beta 1 (Beta Catenin or CTNNB1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 3,500 ｜ Global Markets Direct ｜ 2022年9月 ｜ 英文レポート
- Catenin Beta 1 (Beta Catenin or CTNNB1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report 'Catenin Beta 1 - Drugs In Development, 2022'; Catenin Beta 1 (Beta C…
- このレポートの詳細ページはこちら
- Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 3,500 ｜ Global Markets Direct ｜ 2022年8月 ｜ 英文レポート
- Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Estrogen Receptor Beta (ER Bet…
- このレポートの詳細ページはこちら
- Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 3,500 ｜ Global Markets Direct ｜ 2022年8月 ｜ 英文レポート
- Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recen…
- このレポートの詳細ページはこちら
- Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 3,500 ｜ Global Markets Direct ｜ 2022年8月 ｜ 英文レポート
- Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Retinoic Acid Receptor…
- このレポートの詳細ページはこちら
- Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 3,500 ｜ Global Markets Direct ｜ 2022年8月 ｜ 英文レポート
- Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Placenta Growth Factor (Vascular Endothelial G…
- このレポートの詳細ページはこちら
- Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ 2022年8月 ｜ 英文レポート
- Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide…
- このレポートの詳細ページはこちら
- 臨床試験支援サービスの世界市場予測 2022-2030
- GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET FORECAST 2022-2030
- 価格 US$ 2,900 ｜ Inkwood Research ｜ 2022年9月 ｜ 英文レポート
- KEY FINDINGSThe global clinical trials support services market is estimated to boost with a 7.65% CAGR during the assessment period, 2022-2030. The market growth is driven by the rising prevalence of chronic disease & virus outbreaks and various benefits …
- このレポートの詳細ページはこちら
- 米国臨床試験支援サービス市場予測 2022-2028
- UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET FORECAST 2022-2028
- 価格 US$ 1,100 ｜ Inkwood Research ｜ 2022年9月 ｜ 英文レポート
- KEY FINDINGSThe United States clinical trials support services market is set to surge with a 7.32% CAGR during the forecast period, 2022-2028. The presence of numerous global companies and the availability of different registered studies drive the market …
- このレポートの詳細ページはこちら
- 北米の臨床試験支援サービス市場予測 2022-2030
- NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET FORECAST 2022-2030
- 価格 US$ 1,600 ｜ Inkwood Research ｜ 2022年9月 ｜ 英文レポート
- KEY FINDINGSThe North America clinical trials support services market is set to grow with a 7.20% CAGR between the forecast period, 2022 and 2030. Efficient and cost-saving technologies and the presence of numerous market players boost the market growth i…
- このレポートの詳細ページはこちら
- 欧州臨床試験支援サービス市場予測 2022-2030
- EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET FORECAST 2022-2030
- 価格 US$ 1,600 ｜ Inkwood Research ｜ 2022年9月 ｜ 英文レポート
- KEY FINDINGSThe Europe clinical trials support services market is predicted to record a 7.96% CAGR over the estimation period, 2022 and 2030. Excellent patient recruitment rates and high-quality patient data accelerate market growth in the region.MARKET I…
- このレポートの詳細ページはこちら
- アジア太平洋地域の臨床試験支援サービス市場予測 2022-2030
- ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET FORECAST 2022-2030
- 価格 US$ 1,600 ｜ Inkwood Research ｜ 2022年9月 ｜ 英文レポート
- KEY FINDINGSThe Asia-Pacific clinical trials support services market is estimated to surge with an 8.21% CAGR over the assessment period, 2022 and 2030. The availability of high-quality data at a low price and the presence of a huge population drive marke…
- このレポートの詳細ページはこちら
- ヘルスケア不正検知市場：タイプ別（記述的分析、予測的分析、処方的分析）、コンポーネント別（サービス、ソフトウェア）、アプリケーション別（保険請求レビュー、支払いインテグリティ）、エンドユーザー別（ヘルスケア支払者、政府機関、その他）。世界の機会分析および産業予測、2021-2031年
- Healthcare Fraud Detection Market By Type (Descriptive Analytics, Predictive Analytics, Prescriptive Analysis), By Component (Services, Software), By Application (Insurance Claims Review, Payment Integrity), By End User (Healthcare Payer, Government Agencies, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
- 価格 US$ 5,820 ｜ Allied Market Research ｜ 2022年7月 ｜ 英文レポート
- The global healthcare fraud detection Market was valued at $1,098.2 million in 2021, and is projected to reach $3,600.0 million by 2031, registering a CAGR of 12.6% from 2022 to 2031.The goal of fraud detection is to stop someone from obtaining money or o…
- このレポートの詳細ページはこちら
- ポピュレーションヘルス管理市場：コンポーネント別（ソフトウェア、サービス）、提供形態別（オンプレミス、クラウド型）、エンドユーザー別（医療機関、医療費支払者、その他）。世界の機会分析および産業予測、2021-2031年
- Population Health Management Market By Component (Software, Services), By Mode of Delivery (On-premise, Cloud-based), By End User (Healthcare Providers, Healthcare Payers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
- 価格 US$ 5,820 ｜ Allied Market Research ｜ 2022年7月 ｜ 英文レポート
- The global population health management market was valued at $19,176.22 million in 2021, and is estimated to reach $63,758.84 million by 2031, growing at a CAGR of 12.7% from 2022 to 2031.Population health management (PHM) is practice of improving clinica…
- このレポートの詳細ページはこちら
- ヘモグロビン異常症市場：タイプ別（サラセミア、鎌状赤血球症、その他）、治療法別（モノクローナル抗体薬、ACE阻害剤、ヒドロキシ尿素、その他）、流通チャネル別（病院薬局、オンラインプロバイダー、ドラッグストア、小売薬局）。世界の機会分析および産業予測、2021-2031年
- Hemoglobinopathies Market By Type (Thalassemia, Sickle Cell Disease, Others), By Therapy (Monoclonal Antibody Medication, ACE inhibitors, Hydroxyurea, Others), By Distribution Channel (Hospital Pharmacy, Online Providers, Drug Stores and Retail Pharmacy): Global Opportunity Analysis and Industry Forecast, 2021-2031
- 価格 US$ 5,820 ｜ Allied Market Research ｜ 2022年7月 ｜ 英文レポート
- Hemoglobinopathy is a collective term used for the blood disorder that primarily affects the red blood cells (RBCs). The abnormal production or structural change in the hemoglobin molecule causes hemoglobinopathies. Majorly, hemoglobinopathies are divided…
- このレポートの詳細ページはこちら
- オリゴヌクレオチド合成市場：製品（医薬品、合成オリゴ（プライマー）、試薬）、タイプ（カスタム、設計済み）、用途（治療（ASO、siRNA）、研究（（PCR、シークエンス、診断））、エンドユーザー（医薬品、CROS、CMO）-2027年までの世界市場予測
- Oligonucleotide Synthesis Market by Product (Drug, Synthesized Oligo (Primer), Reagents), Type (Custom, Predesigned), Application (Therapeutic (ASO, siRNA), Research ((PCR, Sequencing, Diagnostics)), End User (Pharma, CROS, CMOs) - Global Forecast to 2027
- 価格 US$ 4,950 ｜ MarketsandMarkets ｜ 2022年11月 ｜ 英文レポート
- The global oligonucleotide synthesis market is projected to reach USD 16.7 billion by 2027 from USD 7.7 billion in 2022, at a CAGR of 16.8% during the forecast period. Market growth can be attributed to the increasing ongoing clinical trials for oligonucl…
- このレポートの詳細ページはこちら
- がん/腫瘍プロファイリング市場：技術（イムノアッセイ、NGS、PCR）、がんタイプ（乳がん、肺がん、大腸がん）、バイオマーカータイプ（ゲノムバイオマーカー、タンパク質バイオマーカー）、アプリケーション（バイオマーカー探索、診断、予後診断）- 2027年までの世界予測
- Cancer/Tumor Profiling Market by Technology (Immunoassay, NGS, PCR), Cancer Type (Breast, Lung, Colorectal), Biomarker Type (Genomic Biomarkers, Protein Biomarkers), Application (Biomarker Discovery, Diagnostics, Prognostics) - Global Forecast to 2027
- 価格 US$ 4,950 ｜ MarketsandMarkets ｜ 2022年11月 ｜ 英文レポート
- The global cancer/tumor profiling market is projected to reach USD 16.0 Billion by 2027 from USD 9.7 Billion in 2022, at a CAGR of 10.6% during the forecast period. Growth in this market is majorly driven by rising funding investments in cancer research a…
- このレポートの詳細ページはこちら
他産業の新着レポートを見る
カテゴリ別にレポートを見る